Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dirk, Usener"'
Autor:
Sabrina Rüggeberg, Antje Wanglin, Özlem Demirel, Rüdiger Hack, Birgit Niederhaus, Bernd Bidlingmaier, Matthias Blumrich, Dirk Usener
Publikováno v:
Animals, Vol 13, Iss 18, p 2953 (2023)
For the quantification of insulin activity, United States Pharmacopeia (USP) general chapter continues to require the rabbit blood sugar test. For new insulin or insulin analogue compounds, those quantitative data are expected for stability or compar
Externí odkaz:
https://doaj.org/article/5598fb50a6014b359b0f56fc3265fa3d
Autor:
Sabrina Rueggeberg, Dirk Mayert, Jochen Maas, Götz Troschau, Norbert Tennagels, Birgit Niederhaus, Wilfried Arz, Dirk Usener, Lea Schneider, Rüdiger Hack, Johannes Meiwes, Stefan Welte
Publikováno v:
ALTEX. :565-566
Autor:
Michael Keese, Dirk Schadendorf, Axel Gerhardt, Stefan B. Eichmüller, Dirk Usener, Jörg Sturm
Publikováno v:
Cancer Letters. 208:197-206
The expression of 14 individual and two groups of tumor antigens was characterized for colorectal carcinoma by RT-PCR using 26 colorectal carcinoma specimens, eight cell lines, six samples of patients with inflammatory bowl diseases, and nine specime
Publikováno v:
International Journal of Cancer. 104:482-487
Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of extra-nodal non-Hodgkin lymphomas with primary manifestation in the skin with poor treatment options in the advanced stages. As basis for future immune-therapeutic strategies we have invest
Publikováno v:
Experimental Dermatology. 11:292-301
Tumor-associated antigens (TAA) are increasingly used as specific targets for immune therapy of malignant melanoma. The aim of the present study was to provide a basis for selecting the most suitable TAA by analyzing the mRNA expression of a large pa
Publikováno v:
Acta Oto-Laryngologica. 122:546-552
Specific immune therapy targeting residual areas of cancer cells may emerge as a powerful treatment strategy for head and neck squamous cell carcinoma (HNSCC). In order to define possible targets for immune therapy, we evaluated the frequency of two
Autor:
Michael Koslowski, Karl Dhaene, Gunda Brandenburg, Ugur Sahin, Christoph Huber, Dirk Usener, Özlem Türeci, Gerhard Seitz
Purpose: Antibody-based cancer therapies have emerged as the most promising therapeutics in oncology. The purpose of this study was to discover novel targets for therapeutic antibodies in solid cancer. Experimental Design: We combined data mining and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398c795348ba342c172e4c2379714e30
https://hdl.handle.net/20.500.14017/dff3ec17-d623-4e5d-a0ed-d47e63bb02b3
https://hdl.handle.net/20.500.14017/dff3ec17-d623-4e5d-a0ed-d47e63bb02b3
Publikováno v:
Methods in molecular medicine. 109
Serological analysis of tumor antigens by recombinant cDNA expression cloning (SEREX) allows the systematic cloning of tumor antigens recognized by the spontaneous autoantibody repertoire of cancer patients. For SEREX, cDNA expression libraries are c
Serological analysis of tumor antigens by recombinant cDNA expression cloning (SEREX) allows the systematic cloning of tumor antigens recognized by the spontaneous autoantibody repertoire of cancer patients. For SEREX, cDNA expression libraries are c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f88445641b87f4f081fe0c1888c3424d
https://doi.org/10.1385/1-59259-862-5:137
https://doi.org/10.1385/1-59259-862-5:137
Publikováno v:
The Journal of investigative dermatology. 121(1)
cTAGE-1 is a cutaneous-T-cell-lymphoma-specific tumor antigen recently identified by serologic identification of antigens by recombinant expression cloning. This study was aimed at identifying and characterizing related genes. Rapid amplification of